Table 1.

Patient Values for AC and AH Patients at Sample Acquisition

	Alcoholic Cirrhosis (AC)	Total Alcoholic Hepatitis (AH)	Surviving Alcoholic Hepatitis (SV)	Nonsurviving Alcoholic Hepatitis (NS)
n	27	24	14	10
Age	51 ± 2.2	44 ± 3*	39 ± 3	51 ± 4
Sex (% male)	66%	56%	57%	60%
AST (U/L)	77 ± 12	115 ± 16	126 ± 24	99 ± 22
ALT (U/L)	38 ± 8	47 ± 8	50 ± 10	43 ± 15
GDH (U/L)	33 ± 11	40 ± 9	28 ± 11	55 ± 15
Bilirubin (mg/dl)	3.3 ± 0.65	19.0 ± 2.2*	15.7 ± 2.3*	23.5 ± 4.0*
Creatinine (mg/dl)	1.2 ± 0.1	1.5 ± 0.2*	1.3 ± 0.3	1.8 ± 0.3*
INR	1.5 ± 0.13	2.3 ± 0.2*	2.3 ± 0.3*	2.3 ± 0.2*
WBC	6.6 ± 0.5	10.6 ± 1.0*	9.6 ± 1.4*	11.9 ± 1.7*
LDH (U/L)	303 ± 34	509 ± 80	513 ± 85*	503 ± 163
CK (U/L)	153 ± 80	247 ± 102	244 ± 110	252 ± 204
ALP (U/L)	53 ± 8	73 ± 16	67 ± 10	82 ± 36
ABIC score	6.9 ± 0.3	8.2 ± 0.4*	7.4 ± 0.5	9.3 ± 0.5*†
MELD score	15.3 ± 1.2	31.1 ± 1.6*	29.1 ± 2.7*	34.0 ± 2.1*
30-Day mortality	0%	41.6%	0%	100%

The ABIC score was calculated as in Dominguez and coworkers5, and the MELD score was calculated as in Sheth et al.42. ANOVA was used to compare all three groups (AC, SV, and NS), and a t-test (nonparametric or parametric as appropriate) was used to compare two groups (AC, AH or SV, NS).

*p < 0.05, AH versus AC; †p < 0.05, NS versus SV.